ArticleCellular oncology (Dordrecht, Netherlands)2025

EGFR blockade confers sensitivity to pan-RAS inhibitors in KRAS-mutated cancers.

Junling Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.